Evidence map›Paper›PMID 41970682›Full record

ArticleEndoscopy international open2026

Development of a national root cause analysis system for post-endoscopy upper gastrointestinal cancer.

Amar Srinivasa, Rebeca Fiadeiro, Tim Gentry, Shilpi Goel, Tameera Rahman, Karen Clements, Warren Chapman, Nicholas Burr, Dipankar Mukherjee, Matthew Banks and 4 more

Abstract read
In one paragraph

Article in Endoscopy international open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Amar SrinivasaGastroenterology, Sandwell and West Birmingham NHS Trust, West Bromwich, United Kingdom of Great Britain and Northern Ireland.ORCID 0000-0003-2271-8462
Rebeca FiadeiroHealth Data Insight CIC, Cambridge, United Kingdom of Great Britain and Northern Ireland.
Tim GentryHealth Data Insight CIC, Cambridge, United Kingdom of Great Britain and Northern Ireland.
Shilpi GoelHealth Data Insight CIC, Cambridge, United Kingdom of Great Britain and Northern Ireland.
Tameera RahmanHealth Data Insight CIC, Cambridge, United Kingdom of Great Britain and Northern Ireland.
Karen ClementsHealth Data Insight CIC, Cambridge, United Kingdom of Great Britain and Northern Ireland.
Warren ChapmanGastroenterology, Sandwell and West Birmingham NHS Trust, West Bromwich, United Kingdom of Great Britain and Northern Ireland.
Nicholas BurrCancer Epidemiology Group, Institute of Cancer & Pathology and Institute of Data Analytics, Leeds University, Leeds, United Kingdom of Great Britain and Northern Ireland.
Dipankar MukherjeeBarking Havering and Redbridge Hospitals NHS Trust, Romford, United Kingdom of Great Britain and Northern Ireland.
Matthew BanksDepartment of Gastroenterology, University College London Hospitals NHS Foundation Trust, London, United Kingdom of Great Britain and Northern Ireland.
Mimi McCordHeartburn Cancer UK, Heartburn Cancer UK, Chichester, United Kingdom of Great Britain and Northern Ireland.
Anjan DharCounty Durham and Darlington NHS Foundation Trust, Darlington, United Kingdom of Great Britain and Northern Ireland.
Roland ValoriGloucestershire Hospitals NHS Trust, Gloucester, United Kingdom of Great Britain and Northern Ireland.
Nigel TrudgillDepartment of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom of Great Britain and Northern Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and study aims: Post-endoscopy upper gastrointestinal cancer (PEUGIC) is a key performance indicator for endoscopy. PEUGIC represents a delay in diagnosis: a patient has an endoscopy that did not diagnose cancer, and another investigation, usually endoscopy, 3 to 36 months later that diagnoses upper gastrointestinal (UGI) cancer. We describe a national system to identify PEUGIC and undertake root cause analysis. Methods: This retrospective national study was undertaken in the English National Health Service (NHS) and consisted of: 1) identification of PEUGIC; 2) development of an online platform for root cause analysis; and 3) pooled national analysis of PEUGIC. Two national datasets--Hospital Episode Statistics and National Cancer Registration and Analysis Service's cancer registry--enabled identification of people diagnosed with UGI cancer who had endoscopy in the previous 3 to 36 months without a cancer diagnosis (PEUGIC). The online portal informed every endoscopy provider of their PEUGIC and enabled a comprehensive root cause analysis. Results: This methodology was successful in identifying 3907 PEUGIC from January 1, 2017 to October 30, 2023. Root cause analysis was completed for 2666 PEUGIC during the study period and represents the world's largest cohort of PEUGIC. 664 (17%) PEUGIC were ineligible on local review as they did not meet study criteria. Conclusions: A process to identify PEUGIC across a national healthcare system and to perform root cause analysis is described. The methodology is transferable to other healthcare systems with large national datasets, but even without such datasets, the root cause analysis process developed allows identification of learning from PEUGIC for local endoscopy quality improvement.

Indexed as

Endoscopy Upper GI TractPerformance and complicationsQuality and logistical aspectsQuality management

Identifiers

PMID41970682
PMCPMC13063305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.